Cargando…
Long‐term dosimetric stability of multiple TomoTherapy delivery systems
The dosimetric stability of six TomoTherapy units was analyzed to investigate changes in performance over time and with system upgrades. Energy and output were tracked using monitor chamber signal, onboard megavoltage computed tomography (MVCT) detector profile, and external ion chamber measurements...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689853/ https://www.ncbi.nlm.nih.gov/pubmed/28464517 http://dx.doi.org/10.1002/acm2.12085 |
_version_ | 1783279471364669440 |
---|---|
author | Smilowitz, Jennifer B. Dunkerley, David Hill, Patrick M. Yadav, Poonam Geurts, Mark W. |
author_facet | Smilowitz, Jennifer B. Dunkerley, David Hill, Patrick M. Yadav, Poonam Geurts, Mark W. |
author_sort | Smilowitz, Jennifer B. |
collection | PubMed |
description | The dosimetric stability of six TomoTherapy units was analyzed to investigate changes in performance over time and with system upgrades. Energy and output were tracked using monitor chamber signal, onboard megavoltage computed tomography (MVCT) detector profile, and external ion chamber measurements. The systems (and monitoring periods) include three Hi‐Art (67, 61, and 65 mos.), two TomoHDA (31 and 26 mos.), and one Radixact unit (11 mos.), representing approximately 10 years of clinical use. The four newest systems use the Dose Control Stability (DCS) system and Fixed Target Linear Accelerator (linac) (FTL). The output stability is reported as deviation from reference monitor chamber signal for all systems and/or from an external chamber signal. The energy stability was monitored using relative (center versus off‐axis) MVCT detector signal (beam profile) and/or the ratio of chamber measurements at 2 depths. The clinical TomoHDA data were used to benchmark the Radixact stability, which has the same FTL but runs at a higher dose rate. The output based on monitor chamber data of all systems is very stable. The standard deviation of daily output on the non‐DCS systems was 0.94–1.52%. As expected, the DCS systems had improved standard deviation: 0.004–0.06%. The beam energy was also very stable for all units. The standard deviation in profile flatness was 0.23–0.62% for rotating target systems and 0.04–0.09% for FTL. Ion chamber output and PDD ratios supported these results. The output stability on the Radixact system during extended treatment delivery (20, 30, and 40 min) was comparable to a clinical TomoHDA system. For each system, results are consistent between different measurement tools and techniques, proving not only the dosimetric stability, but also these quality parameters can be confirmed with various metrics. The replacement history over extended time periods of the major dosimetric components of the different delivery systems (target, linac, and magnetron) is also reported. |
format | Online Article Text |
id | pubmed-5689853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56898532018-04-02 Long‐term dosimetric stability of multiple TomoTherapy delivery systems Smilowitz, Jennifer B. Dunkerley, David Hill, Patrick M. Yadav, Poonam Geurts, Mark W. J Appl Clin Med Phys Radiation Oncology Physics The dosimetric stability of six TomoTherapy units was analyzed to investigate changes in performance over time and with system upgrades. Energy and output were tracked using monitor chamber signal, onboard megavoltage computed tomography (MVCT) detector profile, and external ion chamber measurements. The systems (and monitoring periods) include three Hi‐Art (67, 61, and 65 mos.), two TomoHDA (31 and 26 mos.), and one Radixact unit (11 mos.), representing approximately 10 years of clinical use. The four newest systems use the Dose Control Stability (DCS) system and Fixed Target Linear Accelerator (linac) (FTL). The output stability is reported as deviation from reference monitor chamber signal for all systems and/or from an external chamber signal. The energy stability was monitored using relative (center versus off‐axis) MVCT detector signal (beam profile) and/or the ratio of chamber measurements at 2 depths. The clinical TomoHDA data were used to benchmark the Radixact stability, which has the same FTL but runs at a higher dose rate. The output based on monitor chamber data of all systems is very stable. The standard deviation of daily output on the non‐DCS systems was 0.94–1.52%. As expected, the DCS systems had improved standard deviation: 0.004–0.06%. The beam energy was also very stable for all units. The standard deviation in profile flatness was 0.23–0.62% for rotating target systems and 0.04–0.09% for FTL. Ion chamber output and PDD ratios supported these results. The output stability on the Radixact system during extended treatment delivery (20, 30, and 40 min) was comparable to a clinical TomoHDA system. For each system, results are consistent between different measurement tools and techniques, proving not only the dosimetric stability, but also these quality parameters can be confirmed with various metrics. The replacement history over extended time periods of the major dosimetric components of the different delivery systems (target, linac, and magnetron) is also reported. John Wiley and Sons Inc. 2017-05-02 /pmc/articles/PMC5689853/ /pubmed/28464517 http://dx.doi.org/10.1002/acm2.12085 Text en © 2017 University of Wisconsin. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Smilowitz, Jennifer B. Dunkerley, David Hill, Patrick M. Yadav, Poonam Geurts, Mark W. Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title | Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title_full | Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title_fullStr | Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title_full_unstemmed | Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title_short | Long‐term dosimetric stability of multiple TomoTherapy delivery systems |
title_sort | long‐term dosimetric stability of multiple tomotherapy delivery systems |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689853/ https://www.ncbi.nlm.nih.gov/pubmed/28464517 http://dx.doi.org/10.1002/acm2.12085 |
work_keys_str_mv | AT smilowitzjenniferb longtermdosimetricstabilityofmultipletomotherapydeliverysystems AT dunkerleydavid longtermdosimetricstabilityofmultipletomotherapydeliverysystems AT hillpatrickm longtermdosimetricstabilityofmultipletomotherapydeliverysystems AT yadavpoonam longtermdosimetricstabilityofmultipletomotherapydeliverysystems AT geurtsmarkw longtermdosimetricstabilityofmultipletomotherapydeliverysystems |